Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 119

1.

Demographic and clinical characteristics of chikungunya patients from six Colombian cities, 2014-2015.

Rueda JC, Santos AM, Angarita JI, Giraldo RB, Saldarriaga EL, Ballesteros Muñoz JG, Forero E, Valencia H, Somoza F, Martin-Arsanios D, Quintero EJ, Reyes-Martinez V, Padilla D, Cuervo FM, Peláez-Ballestas I, Cardiel MH, Pavía PX, Londono J.

Emerg Microbes Infect. 2019;8(1):1490-1500. doi: 10.1080/22221751.2019.1678366.

2.

Correction to: Clinical predictors of remission and low disease activity in Latin American early rheumatoid arthritis: data from the GLADAR cohort.

Gamboa-Cárdenas RV, Ugarte-Gil MF, Massardo L, Sacnun MP, Saurit V, Cardiel MH, Soriano ER, Pisoni C, Galarza-Maldonado CM, Rios C, Radominski SC, Castelar-Pinheiro GDR, Bianchi WA, Appenzeller S, da Silveira IG, de Freitas Zerbini CA, Caballero-Uribe CV, Rojas-Villarraga A, Guibert-Toledano M, Ballesteros F, Montufar R, Vázquez-Mellado J, Esquivel-Valerio J, De La Torre IG, Barile-Fabris LA, Palezuelos FI, Andrade-Ortega L, Monge P, Teijeiro R, Achurra-Castillo ÁF, Esteva Spinetti MH, Alarcón GS, Pons-Estel BA.

Clin Rheumatol. 2019 Oct;38(10):2963-2964. doi: 10.1007/s10067-019-04742-8.

PMID:
31432337
3.

Two-Year Safety and Effectiveness of Peficitinib in Moderate-To-Severe Rheumatoid Arthritis: A Phase IIb, Open-Label Extension Study.

Genovese MC, Greenwald MW, Gutierrez-Ureña SR, Cardiel MH, Poiley JE, Zubrzycka-Sienkiewicz A, Codding CE, Wang A, He W, Amos R, Vinueza R, Wang X, Garg JP, Kivitz AJ.

Rheumatol Ther. 2019 Dec;6(4):503-520. doi: 10.1007/s40744-019-00167-6. Epub 2019 Aug 13.

4.

Factors predictive of serious infections over time in systemic lupus erythematosus patients: data from a multi-ethnic, multi-national, Latin American lupus cohort.

Pimentel-Quiroz VR, Ugarte-Gil MF, Harvey GB, Wojdyla D, Pons-Estel GJ, Quintana R, Esposto A, García MA, Catoggio LJ, Cardiel MH, Barile LA, Amigo MC, Sato EI, Bonfa E, Borba E, Lavras Costallat LT, Neira OJ, Massardo L, Guibert-Toledano M, Chacón-Díaz R, Alarcón GS, Pons-Estel BA.

Lupus. 2019 Aug;28(9):1101-1110. doi: 10.1177/0961203319860579. Epub 2019 Jul 10.

PMID:
31291843
5.

Clinical predictors of remission and low disease activity in Latin American early rheumatoid arthritis: data from the GLADAR cohort.

Gamboa-Cárdenas RV, Ugarte-Gil MF, Loreto M, Sacnun MP, Saurit V, Cardiel MH, Soriano ER, Pisoni C, Galarza-Maldonado CM, Rios C, Radominski SC, Castelar-Pinheiro GDR, Bianchi WA, Appenzeller S, da Silveira IG, de Freitas Zerbini CA, Caballero-Uribe CV, Rojas-Villarraga A, Guibert-Toledano M, Ballesteros F, Montufar R, Vázquez-Mellado J, Esquivel-Valerio J, De La Torre IG, Barile-Fabris LA, Palezuelos FI, Andrade-Ortega L, Monge P, Teijeiro R, Achurra-Castillo ÁF, Esteva Spinetti MH, Alarcón GS, Pons-Estel BA.

Clin Rheumatol. 2019 Oct;38(10):2737-2746. doi: 10.1007/s10067-019-04618-x. Epub 2019 Jun 3. Erratum in: Clin Rheumatol. 2019 Aug 20;:.

PMID:
31161486
6.

Update of the Mexican College of Rheumatology Guidelines for the Pharmacological Treatment of Rheumatoid Arthritis, 2018.

Cardiel MH, Carrillo S, Pérez M, Andrade L, Pacheco Tena C, Silveira LH, Limón L, Cerpa S, Gutiérrez Ureña S, Durán S, Irazoque Palazuelos F, Muñoz López S, Sicsik Ayala SA, Barile L, Ramos Sánchez MA, Grajeda Portes D, Portela M, Hernández Bedolla A, García-Figueroa JL, Montero M, Abud-Mendoza C, Martínez Martínez MU, Herrera van Ostdam D, Pascual-Ramos V, Merayo-Chalico J, Guzmán-Sánchez I, Pérez-Bastidas ME, Aguilar Arreola JE, López Rodríguez A, Reyes-Cordero G, Ricardez HA, Hernández Cabrera MF, Olvera-Soto G, Xibillé Friedmann D.

Reumatol Clin. 2019 May 15. pii: S1699-258X(19)30079-8. doi: 10.1016/j.reuma.2019.04.002. [Epub ahead of print] English, Spanish.

7.

Predictors of Remission and Low Disease Activity State in Systemic Lupus Erythematosus: Data from a Multiethnic, Multinational Latin American Cohort.

Ugarte-Gil MF, Wojdyla D, Pons-Estel GJ, Quintana R, Gómez-Puerta JA, Catoggio LJ, Alvarellos A, Saurit V, Borba E, Sato E, Costallat L, Da Silva NA, Iglesias-Gamarra A, Neira O, Reyes-Llerena G, Cardiel MH, Amigo MC, Acevedo-Vásquez E, Esteva-Spinetti MH, Alarcón GS, Pons-Estel BA.

J Rheumatol. 2019 Oct;46(10):1299-1308. doi: 10.3899/jrheum.180433. Epub 2019 Mar 1.

PMID:
30824636
8.

Tofacitinib in Combination With Methotrexate in Patients With Rheumatoid Arthritis: Clinical Efficacy, Radiographic, and Safety Outcomes From a Twenty-Four-Month, Phase III Study.

van der Heijde D, Strand V, Tanaka Y, Keystone E, Kremer J, Zerbini CAF, Cardiel MH, Cohen S, Nash P, Song YW, Tegzová D, Gruben D, Wallenstein G, Connell CA, Fleischmann R; ORAL Scan Investigators.

Arthritis Rheumatol. 2019 Jun;71(6):878-891. doi: 10.1002/art.40803. Epub 2019 Apr 24.

9.

Response to: 'Clinical evidence guidelines in systemic lupus erythematosus: revaluation' by Scheinberg.

Pons-Estel BA, Bonfa E, Soriano ER, Cardiel MH, Izcovich A, Vázquez G, Alarcón GS.

Ann Rheum Dis. 2019 Nov;78(11):e120. doi: 10.1136/annrheumdis-2018-214385. Epub 2018 Oct 23. No abstract available.

PMID:
30352890
10.

First Latin American clinical practice guidelines for the treatment of systemic lupus erythematosus: Latin American Group for the Study of Lupus (GLADEL, Grupo Latino Americano de Estudio del Lupus)-Pan-American League of Associations of Rheumatology (PANLAR).

Pons-Estel BA, Bonfa E, Soriano ER, Cardiel MH, Izcovich A, Popoff F, Criniti JM, Vásquez G, Massardo L, Duarte M, Barile-Fabris LA, García MA, Amigo MC, Espada G, Catoggio LJ, Sato EI, Levy RA, Acevedo Vásquez EM, Chacón-Díaz R, Galarza-Maldonado CM, Iglesias Gamarra AJ, Molina JF, Neira O, Silva CA, Vargas Peña A, Gómez-Puerta JA, Scolnik M, Pons-Estel GJ, Ugolini-Lopes MR, Savio V, Drenkard C, Alvarellos AJ, Ugarte-Gil MF, Babini A, Cavalcanti A, Cardoso Linhares FA, Haye Salinas MJ, Fuentes-Silva YJ, Montandon de Oliveira E Silva AC, Eraso Garnica RM, Herrera Uribe S, Gómez-Martín D, Robaina Sevrini R, Quintana RM, Gordon S, Fragoso-Loyo H, Rosario V, Saurit V, Appenzeller S, Dos Reis Neto ET, Cieza J, González Naranjo LA, González Bello YC, Collado MV, Sarano J, Retamozo S, Sattler ME, Gamboa-Cárdenas RV, Cairoli E, Conti SM, Amezcua-Guerra LM, Silveira LH, Borba EF, Pera MA, Alba Moreyra PB, Arturi V, Berbotto GA, Gerling C, Gobbi CA, Gervasoni VL, Scherbarth HR, Brenol JCT, Cavalcanti F, Costallat LTL, Da Silva NA, Monticielo OA, Seguro LPC, Xavier RM, Llanos C, Montúfar Guardado RA, Garcia de la Torre I, Pineda C, Portela Hernández M, Danza A, Guibert-Toledano M, Reyes GL, Acosta Colman MI, Aquino AM, Mora-Trujillo CS, Muñoz-Louis R, García Valladares I, Orozco MC, Burgos PI, Betancur GV, Alarcón GS; Grupo Latino Americano de Estudio del Lupus (GLADEL) and Pan-American League of Associations of Rheumatology (PANLAR).

Ann Rheum Dis. 2018 Nov;77(11):1549-1557. doi: 10.1136/annrheumdis-2018-213512. Epub 2018 Jul 25.

11.

Baricitinib for systemic lupus erythematosus: a double-blind, randomised, placebo-controlled, phase 2 trial.

Wallace DJ, Furie RA, Tanaka Y, Kalunian KC, Mosca M, Petri MA, Dörner T, Cardiel MH, Bruce IN, Gomez E, Carmack T, DeLozier AM, Janes JM, Linnik MD, de Bono S, Silk ME, Hoffman RW.

Lancet. 2018 Jul 21;392(10143):222-231. doi: 10.1016/S0140-6736(18)31363-1. Erratum in: Lancet. 2018 Aug 11;392(10146):476.

PMID:
30043749
12.

A Consensus Position Paper From REAL-PANLAR Group About the Methodological Approach for the Accreditation Process of Centers of Excellence in Rheumatoid Arthritis in Latin America.

Santos-Moreno P, Caballero-Uribe CV, Cardiel MH, Galarza-Maldonado C, Massardo L, Pineda C, Soriano E, Castro CA, Villarreal L, Buitrago D.

J Clin Rheumatol. 2019 Jan;25(1):54-58. doi: 10.1097/RHU.0000000000000773.

PMID:
29596208
13.

Therapeutic Guidelines for Latin American Lupus Patients: Methodology.

Cardiel MH, Soriano ER, Bonfá ESDO, Alarcón GS, Izcovich A, Amigo Castañeda MC, Barile-Fabris LA, Duarte M, Espada G, García MA, Levy RA, Massardo L, Sato EI, Vásquez G, Acevedo-Vásquez EM, Catoggio LJ, Chacón-Díaz R, Galarza Maldonado CM, Iglesias Gamarra AJ, Molina Restrepo JF, Neira O, Silva CA, Vargas Peña A, Pons-Estel BA.

J Clin Rheumatol. 2018 Jan;24(1):41-44. doi: 10.1097/RHU.0000000000000662. No abstract available.

PMID:
29200029
14.

Educational website incorporating rheumatoid arthritis patient needs for Latin American and Caribbean countries.

Massone F, Martínez ME, Pascual-Ramos V, Quintana R, Stange L, Caballero-Uribe CV, Ferreyra-Garrot L, Kourilovitch M, Duarte M, Baumert C, Vergara C, Gareca N, Rodríguez C, Khoury V, Medina M, Cardiel MH, Massardo L.

Clin Rheumatol. 2017 Dec;36(12):2789-2797. doi: 10.1007/s10067-017-3866-4. Epub 2017 Nov 2.

PMID:
29098475
15.

Effects of Amerindian Genetic Ancestry on Clinical Variables and Therapy in Patients with Rheumatoid Arthritis.

Sánchez E, García de la Torre I, Sacnún M, Goñi M, Berbotto G, Paira S, Musuruana JL, Graf C, Alvarellos A, Messina OD, Babini A, Strusberg I, Marcos JC, Scherbarth H, Spindler A, Quinteros A, Toloza S, Moreno JLC, Catoggio LJ, Tate G, Eimon A, Citera G, Pellet AC, Nasswetter G, Cardiel MH, Miranda P, Ballesteros F, Esquivel-Valerio JA, Maradiaga-Ceceña MA, Acevedo-Vásquez EM, García CG, Tusié-Luna T, Pons-Estel BA, Alarcón-Riquelme ME; GENAR Study.

J Rheumatol. 2017 Dec;44(12):1804-1812. doi: 10.3899/jrheum.160485. Epub 2017 Nov 1.

PMID:
29093158
16.

Remission and Low Disease Activity Status (LDAS) protect lupus patients from damage occurrence: data from a multiethnic, multinational Latin American Lupus Cohort (GLADEL).

Ugarte-Gil MF, Wojdyla D, Pons-Estel GJ, Catoggio LJ, Drenkard C, Sarano J, Berbotto GA, Borba EF, Sato EI, Tavares Brenol JC, Uribe O, Ramirez Gómez LA, Guibert-Toledano M, Massardo L, Cardiel MH, Silveira LH, Chacón-Diaz R, Alarcón GS, Pons-Estel BA; GLADEL.

Ann Rheum Dis. 2017 Dec;76(12):2071-2074. doi: 10.1136/annrheumdis-2017-211814. Epub 2017 Sep 22.

PMID:
28939626
17.

Prognostic Factors for Permanent Work Disability in Patients With Rheumatoid Arthritis Who Received Combination Therapy of Conventional Synthetic Disease-Modifying Antirheumatic Drugs: A Retrospective Cohort Study.

Vazquez-Villegas ML, Gamez-Nava JI, Celis A, Sanchez-Mosco D, de la Cerda-Trujillo LF, Murillo-Vazquez JD, Saldaña-Cruz AM, Alcaraz-Lopez MF, Diaz-Rizo V, Alvarez-Nemegyei J, Cardiel MH, Gonzalez-Lopez L.

J Clin Rheumatol. 2017 Oct;23(7):376-382. doi: 10.1097/RHU.0000000000000582.

PMID:
28937473
18.

Transancestral mapping and genetic load in systemic lupus erythematosus.

Langefeld CD, Ainsworth HC, Cunninghame Graham DS, Kelly JA, Comeau ME, Marion MC, Howard TD, Ramos PS, Croker JA, Morris DL, Sandling JK, Almlöf JC, Acevedo-Vásquez EM, Alarcón GS, Babini AM, Baca V, Bengtsson AA, Berbotto GA, Bijl M, Brown EE, Brunner HI, Cardiel MH, Catoggio L, Cervera R, Cucho-Venegas JM, Dahlqvist SR, D'Alfonso S, Da Silva BM, de la Rúa Figueroa I, Doria A, Edberg JC, Endreffy E, Esquivel-Valerio JA, Fortin PR, Freedman BI, Frostegård J, García MA, de la Torre IG, Gilkeson GS, Gladman DD, Gunnarsson I, Guthridge JM, Huggins JL, James JA, Kallenberg CGM, Kamen DL, Karp DR, Kaufman KM, Kottyan LC, Kovács L, Laustrup H, Lauwerys BR, Li QZ, Maradiaga-Ceceña MA, Martín J, McCune JM, McWilliams DR, Merrill JT, Miranda P, Moctezuma JF, Nath SK, Niewold TB, Orozco L, Ortego-Centeno N, Petri M, Pineau CA, Pons-Estel BA, Pope J, Raj P, Ramsey-Goldman R, Reveille JD, Russell LP, Sabio JM, Aguilar-Salinas CA, Scherbarth HR, Scorza R, Seldin MF, Sjöwall C, Svenungsson E, Thompson SD, Toloza SMA, Truedsson L, Tusié-Luna T, Vasconcelos C, Vilá LM, Wallace DJ, Weisman MH, Wither JE, Bhangale T, Oksenberg JR, Rioux JD, Gregersen PK, Syvänen AC, Rönnblom L, Criswell LA, Jacob CO, Sivils KL, Tsao BP, Schanberg LE, Behrens TW, Silverman ED, Alarcón-Riquelme ME, Kimberly RP, Harley JB, Wakeland EK, Graham RR, Gaffney PM, Vyse TJ.

Nat Commun. 2017 Jul 17;8:16021. doi: 10.1038/ncomms16021.

19.

Prevalence of musculoskeletal manifestations and related disabilities in a Peruvian urban population living at high altitude. COPCORD Study. Stage I.

Vega-Hinojosa O, Cardiel MH, Ochoa-Miranda P.

Reumatol Clin. 2018 Sep - Oct;14(5):278-284. doi: 10.1016/j.reuma.2017.01.011. Epub 2017 Mar 9. English, Spanish.

20.

Safety of Tofacitinib in the Treatment of Rheumatoid Arthritis in Latin America Compared With the Rest of the World Population.

Castañeda OM, Romero FJ, Salinas A, Citera G, Mysler E, Rillo O, Radominski SC, Cardiel MH, Jaller JJ, Alvarez-Moreno C, Ponce de Leon D, Castelli G, García EG, Kwok K, Rojo R.

J Clin Rheumatol. 2017 Jun;23(4):193-199. doi: 10.1097/RHU.0000000000000498.

PMID:
28145906
21.

Peficitinib, a JAK Inhibitor, in Combination With Limited Conventional Synthetic Disease-Modifying Antirheumatic Drugs in the Treatment of Moderate-to-Severe Rheumatoid Arthritis.

Genovese MC, Greenwald M, Codding C, Zubrzycka-Sienkiewicz A, Kivitz AJ, Wang A, Shay K, Wang X, Garg JP, Cardiel MH.

Arthritis Rheumatol. 2017 May;69(5):932-942. doi: 10.1002/art.40054.

22.

Factors Associated with Health-Related Quality of Life in Mexican Lupus Patients Using the LupusQol.

Etchegaray-Morales I, Méndez-Martínez S, Jiménez-Hernández C, Mendoza-Pinto C, Alonso-García NE, Montiel-Jarquín A, López-Colombo A, García-Villaseñor A, Cardiel MH, García-Carrasco M.

PLoS One. 2017 Jan 23;12(1):e0170209. doi: 10.1371/journal.pone.0170209. eCollection 2017.

23.

Tofacitinib, an oral Janus kinase inhibitor, for the treatment of Latin American patients with rheumatoid arthritis: Pooled efficacy and safety analyses of Phase 3 and long-term extension studies.

Radominski SC, Cardiel MH, Citera G, Goecke A, Jaller JJ, Lomonte ABV, Miranda P, Velez P, Xibillé D, Kwok K, Rojo R, García EG.

Reumatol Clin. 2017 Jul - Aug;13(4):201-209. doi: 10.1016/j.reuma.2016.04.010. Epub 2016 Jun 15. English, Spanish.

24.

Early discoid lupus erythematosus protects against renal disease in patients with systemic lupus erythematosus: longitudinal data from a large Latin American cohort.

Pons-Estel GJ, Aspey LD, Bao G, Pons-Estel BA, Wojdyla D, Saurit V, Alvarellos A, Caeiro F, Haye Salinas MJ, Sato EI, Soriano ER, Costallat LT, Neira O, Iglesias-Gamarra A, Reyes-Llerena G, Cardiel MH, Acevedo-Vásquez EM, Chacón-Díaz R, Drenkard C.

Lupus. 2017 Jan;26(1):73-83. Epub 2016 May 26.

PMID:
27230554
25.

Prevalence of musculoskeletal disorders and rheumatic diseases in Cuenca, Ecuador: a WHO-ILAR COPCORD study.

Guevara-Pacheco S, Feicán-Alvarado A, Sanín LH, Vintimilla-Ugalde J, Vintimilla-Moscoso F, Delgado-Pauta J, Lliguisaca-Segarra A, Dután-Erráez H, Guevara-Mosquera D, Ochoa-Robles V, Cardiel MH, Peláez-Ballestas I.

Rheumatol Int. 2016 Sep;36(9):1195-204. doi: 10.1007/s00296-016-3446-y. Epub 2016 Mar 29.

PMID:
27023004
26.

Evaluation of clopidogrel response variability and identification of the CYP2C19 polymorphism in Mexican patients.

Viveros ME, Areán C, Gutiérrez S, Vázquez S, Cardiel MH, Taboada A, Marín G, Solorio R, García N.

Arch Cardiol Mex. 2016 Oct - Dec;86(4):297-304. doi: 10.1016/j.acmx.2016.01.007. Epub 2016 Mar 9.

PMID:
26971130
27.

Association of anti-Ro52, anti-Ro60 and anti-La antibodies with diagnostic, clinical and laboratory features in a referral hospital in Jerez, Spain.

Menor Almagro R, Jurado Roger A, Rodríguez Gutiérrez FJ, Solís Díaz R, Cardiel MH, Salaberri Maestrojuan JJ.

Reumatol Clin. 2016 Sep-Oct;12(5):256-62. doi: 10.1016/j.reuma.2015.10.010. Epub 2015 Dec 25. English, Spanish.

28.

Genome-Wide Association Study in an Amerindian Ancestry Population Reveals Novel Systemic Lupus Erythematosus Risk Loci and the Role of European Admixture.

Alarcón-Riquelme ME, Ziegler JT, Molineros J, Howard TD, Moreno-Estrada A, Sánchez-Rodríguez E, Ainsworth HC, Ortiz-Tello P, Comeau ME, Rasmussen A, Kelly JA, Adler A, Acevedo-Vázquez EM, Cucho-Venegas JM, García-De la Torre I, Cardiel MH, Miranda P, Catoggio LJ, Maradiaga-Ceceña M, Gaffney PM, Vyse TJ, Criswell LA, Tsao BP, Sivils KL, Bae SC, James JA, Kimberly RP, Kaufman KM, Harley JB, Esquivel-Valerio JA, Moctezuma JF, García MA, Berbotto GA, Babini AM, Scherbarth H, Toloza S, Baca V, Nath SK, Aguilar Salinas C, Orozco L, Tusié-Luna T, Zidovetzki R, Pons-Estel BA, Langefeld CD, Jacob CO.

Arthritis Rheumatol. 2016 Apr;68(4):932-43. doi: 10.1002/art.39504.

29.

Report on the First PANLAR Rheumatology Review Course Rheumatoid Arthritis: Challenges and Solutions in Latin America.

Pineda C, Caballero-Uribe CV, Gutiérrez M, Cazenave T, Cardiel MH, Levy R, Espada G, Rose C, Santos-Moreno P, Pons-Estel BA, Muñoz-Louis R, Soriano ER, Reveille JD.

J Clin Rheumatol. 2015 Dec;21(8):435-9. doi: 10.1097/RHU.0000000000000318.

PMID:
26513305
30.

Tuberculosis and other opportunistic infections in tofacitinib-treated patients with rheumatoid arthritis.

Winthrop KL, Park SH, Gul A, Cardiel MH, Gomez-Reino JJ, Tanaka Y, Kwok K, Lukic T, Mortensen E, Ponce de Leon D, Riese R, Valdez H.

Ann Rheum Dis. 2016 Jun;75(6):1133-8. doi: 10.1136/annrheumdis-2015-207319. Epub 2015 Aug 28. Review.

31.

Rheumatoid arthritis in Latin America. Important challenges to be solved.

Burgos Vargas R, Cardiel MH.

Clin Rheumatol. 2015 Mar;34 Suppl 1:S1-3. doi: 10.1007/s10067-015-3048-1. Epub 2015 Aug 9. No abstract available.

32.

Burden of illness of rheumatoid arthritis in Latin America: a regional perspective.

Ramírez LA, Rodríguez C, Cardiel MH.

Clin Rheumatol. 2015 Mar;34 Suppl 1:S9-15. doi: 10.1007/s10067-015-3012-0. Epub 2015 Jul 30. Review.

33.

REAL-PANLAR Project for the Implementation and Accreditation of Centers of Excellence in Rheumatoid Arthritis Throughout Latin America: A Consensus Position Paper From REAL-PANLAR Group on Improvement of Rheumatoid Arthritis Care in Latin America Establishing Centers of Excellence.

Santos-Moreno P, Galarza-Maldonado C, Caballero-Uribe CV, Cardiel MH, Massardo L, Soriano ER, Olano JA, Díaz Coto JF, Durán Pozo GR, da Silveira IG, de Castrejón VJ, Pérez LL, Méndez Justo CA, Montufar Guardado RA, Muños R, Elvir SM, Paredes Domínguez ER, Pons-Estel B, Ríos Acosta CR, Sandino S, Toro Gutiérrez CE, Villegas de Morales SM, Pineda C.

J Clin Rheumatol. 2015 Jun;21(4):175-80. doi: 10.1097/RHU.0000000000000247.

34.

Association of regional and cultural factors with the prevalence of rheumatoid arthritis in the Mexican population: a multilevel analysis.

Moreno-Montoya J, Alvarez-Nemegyei J, Sanin LH, Pérez-Barbosa L, Trejo-Valdivia B, Santana N, Goycochea-Robles MV, Cardiel MH, Riega-Torres J, Maradiaga M, Burgos-Vargas R, Peláez-Ballestas I; GEEMA (Grupo de Estudio Epidemiológico de Enfermedades Músculo Articulares).

J Clin Rheumatol. 2015 Mar;21(2):57-62. doi: 10.1097/RHU.0000000000000223. Erratum in: J Clin Rheumatol. 2015 Jun;21(4):e1.

PMID:
25710855
35.

Lupus in Latin-American patients: lessons from the GLADEL cohort.

Pons-Estel GJ, Catoggio LJ, Cardiel MH, Bonfa E, Caeiro F, Sato E, Massardo L, Molina-Restrepo JF, Toledano MG, Barile-Fabris LA, Amigo MC, Acevedo-Vásquez EM, Abadi I, Wojdyla D, Alarcón-Riquelme ME, Alarcón GS, Pons-Estel BA; GLADEL.

Lupus. 2015 May;24(6):536-45. doi: 10.1177/0961203314567753. Epub 2015 Feb 18. Review.

PMID:
25697768
36.

The Social Gap Index and the prevalence of osteoarthritis in the community: a cross-sectional multilevel study in Mexico.

Rodriguez-Amado J, Moreno-Montoya J, Alvarez-Nemegyei J, Goycochea-Robles MV, Sanin LH, Burgos-Vargas R, Cardiel MH, Garza-Elizondo MA, Maradiaga M, Pelaez-Ballestas I; GEEMA.

Clin Rheumatol. 2016 Jan;35(1):175-82. doi: 10.1007/s10067-014-2776-y. Epub 2014 Sep 18.

PMID:
25227770
37.

Health related quality of life in rheumatoid arthritis, osteoarthritis, diabetes mellitus, end stage renal disease and geriatric subjects. Experience from a General Hospital in Mexico.

Ambriz Murillo Y, Menor Almagro R, Campos-González ID, Cardiel MH.

Reumatol Clin. 2015 Mar-Apr;11(2):68-72. doi: 10.1016/j.reuma.2014.03.006. Epub 2014 May 9. English, Spanish.

38.

Update of the Mexican College of Rheumatology guidelines for the pharmacologic treatment of rheumatoid arthritis.

Cardiel MH, Díaz-Borjón A, Vázquez del Mercado Espinosa M, Gámez-Nava JI, Barile Fabris LA, Pacheco Tena C, Silveira Torre LH, Pascual Ramos V, Goycochea Robles MV, Aguilar Arreola JE, González Díaz V, Alvarez Nemegyei J, González-López Ldel C, Salazar Páramo M, Portela Hernández M, Castro Colín Z, Xibillé Friedman DX, Alvarez Hernández E, Casasola Vargas J, Cortés Hernández M, Flores-Alvarado DE, Martínez Martínez LA, Vega-Morales D, Flores-Suárez LF, Medrano Ramírez G, Barrera Cruz A, García González A, López López SM, Rosete Reyes A, Espinosa Morales R; Mexican College of Rheumatology.

Reumatol Clin. 2014 Jul-Aug;10(4):227-40. doi: 10.1016/j.reuma.2013.10.006. Epub 2013 Dec 14. English, Spanish.

39.

Characterization of knee osteoarthritis in Latin America. A comparative analysis of clinical and health care utilization in Argentina, Brazil, and Mexico.

Burgos-Vargas R, Cardiel MH, Loyola-Sánchez A, De Abreu MM, Pons-Estel BA, Rossignol M, Avouac B, Ferraz MB, Halhol H.

Reumatol Clin. 2014 May-Jun;10(3):152-9. doi: 10.1016/j.reuma.2013.07.013. Epub 2013 Nov 26.

40.

A phase Ib multiple ascending dose study evaluating safety, pharmacokinetics, and early clinical response of brodalumab, a human anti-IL-17R antibody, in methotrexate-resistant rheumatoid arthritis.

Martin DA, Churchill M, Flores-Suarez L, Cardiel MH, Wallace D, Martin R, Phillips K, Kaine JL, Dong H, Salinger D, Stevens E, Russell CB, Chung JB.

Arthritis Res Ther. 2013 Oct 25;15(5):R164. doi: 10.1186/ar4347.

41.

Mestizos with systemic lupus erythematosus develop renal disease early while antimalarials retard its appearance: data from a Latin American cohort.

Pons-Estel GJ, Alarcón GS, Burgos PI, Hachuel L, Boggio G, Wojdyla D, Nieto R, Alvarellos A, Catoggio LJ, Guibert-Toledano M, Sarano J, Massardo L, Vásquez GM, Iglesias-Gamarra A, Lavras Costallat LT, Da Silva NA, Alfaro JL, Abadi I, Segami MI, Huerta G, Cardiel MH, Pons-Estel BA; Grupo Latino Americano de Estudio de Lupus (GLADEL).

Lupus. 2013 Aug;22(9):899-907. doi: 10.1177/0961203313496339. Epub 2013 Jul 15.

42.

Rheumatoid arthritis in Latin Americans enriched for Amerindian ancestry is associated with loci in chromosomes 1, 12, and 13, and the HLA class II region.

López Herráez D, Martínez-Bueno M, Riba L, García de la Torre I, Sacnún M, Goñi M, Berbotto GA, Paira S, Musuruana JL, Graf CE, Alvarellos AJ, Messina OD, Babini AM, Strusberg I, Marcos JC, Scherbarth H, Spindler AJ, Quinteros A, Toloza SM, Moreno JL, Catoggio LJ, Tate G, Eimon A, Citera G, Catalán Pellet A, Nasswetter GG, Cardiel MH, Miranda P, Ballesteros F, Esquivel-Valerio JA, Maradiaga-Ceceña MA, Acevedo-Vásquez EM, García García C, Pons-Estel BA, Alarcón-Riquelme ME.

Arthritis Rheum. 2013 Jun;65(6):1457-67. doi: 10.1002/art.37923.

43.

Tofacitinib (CP-690,550) in patients with rheumatoid arthritis receiving methotrexate: twelve-month data from a twenty-four-month phase III randomized radiographic study.

van der Heijde D, Tanaka Y, Fleischmann R, Keystone E, Kremer J, Zerbini C, Cardiel MH, Cohen S, Nash P, Song YW, Tegzová D, Wyman BT, Gruben D, Benda B, Wallenstein G, Krishnaswami S, Zwillich SH, Bradley JD, Connell CA; ORAL Scan Investigators.

Arthritis Rheum. 2013 Mar;65(3):559-70. doi: 10.1002/art.37816.

44.

Current therapies in rheumatoid arthritis: a Latin American perspective.

Burgos-Vargas R, Catoggio LJ, Galarza-Maldonado C, Ostojich K, Cardiel MH.

Reumatol Clin. 2013 Mar-Apr;9(2):106-12. doi: 10.1016/j.reuma.2012.09.001. Epub 2013 Jan 20. Review.

45.

Treatment of early rheumatoid arthritis in a multinational inception cohort of Latin American patients: the GLADAR experience.

Cardiel MH, Pons-Estel BA, Sacnun MP, Wojdyla D, Saurit V, Marcos JC, Pinto MR, Cordeiro de Azevedo AB, da Silveira IG, Radominski SC, Ximenes AC, Massardo L, Ballesteros F, Rojas-Villarraga A, Oñate RV, Hernandez MP, Esquivel-Valerio JA, García-De La Torre I, Khoury VJ, Millán A, Soriano ER; GLADAR.

J Clin Rheumatol. 2012 Oct;18(7):327-35. doi: 10.1097/RHU.0b013e31826d6610.

PMID:
23047532
46.

Treat to target strategy in rheumatoid arthritis: real benefits.

Cardiel MH.

Reumatol Clin. 2013 Mar-Apr;9(2):101-5. doi: 10.1016/j.reuma.2012.04.004. Epub 2012 Sep 15. Review. English, Spanish.

47.

Impact of genetic ancestry and sociodemographic status on the clinical expression of systemic lupus erythematosus in American Indian-European populations.

Sánchez E, Rasmussen A, Riba L, Acevedo-Vasquez E, Kelly JA, Langefeld CD, Williams AH, Ziegler JT, Comeau ME, Marion MC, García-De La Torre I, Maradiaga-Ceceña MA, Cardiel MH, Esquivel-Valerio JA, Rodriguez-Amado J, Moctezuma JF, Miranda P, Perandones CE, Castel C, Laborde HA, Alba P, Musuruana JL, Goecke IA, Anaya JM, Kaufman KM, Adler A, Glenn SB, Brown EE, Alarcón GS, Kimberly RP, Edberg JC, Vilá LM, Criswell LA, Gilkeson GS, Niewold TB, Martín J, Vyse TJ, Boackle SA, Ramsey-Goldman R, Scofield RH, Petri M, Merrill JT, Reveille JD, Tsao BP, Orozco L, Baca V, Moser KL, Gaffney PM, James JA, Harley JB, Tusié-Luna T, Pons-Estel BA, Jacob CO, Alarcón-Riquelme ME.

Arthritis Rheum. 2012 Nov;64(11):3687-94. doi: 10.1002/art.34650.

48.

Health related quality of life in Mexican women with systemic lupus erythematosus: a descriptive study using SF-36 and LupusQoL(C).

García-Carrasco M, Mendoza-Pinto C, Cardiel MH, Méndez-Martínez S, García-Villaseñor A, Jiménez-Hernández C, Alonso-García NE, Briones-Rojas R, Ramos-Álvarez G, López-Colombo A.

Lupus. 2012 Oct;21(11):1219-24. doi: 10.1177/0961203312456749. Epub 2012 Aug 8.

PMID:
22875651
49.

Early rheumatoid arthritis in Latin America: low socioeconomic status related to high disease activity at baseline.

Massardo L, Pons-Estel BA, Wojdyla D, Cardiel MH, Galarza-Maldonado CM, Sacnun MP, Soriano ER, Laurindo IM, Acevedo-Vásquez EM, Caballero-Uribe CV, Padilla O, Guibert-Toledano ZM, da Mota LM, Montufar RA, Lino-Pérez L, Díaz-Coto JF, Achurra-Castillo AF, Hernández JA, Esteva-Spinetti MH, Ramírez LA, Pineda C, Furst DE.

Arthritis Care Res (Hoboken). 2012 Aug;64(8):1135-43. doi: 10.1002/acr.21680.

50.

Cushing's disease as a cause of severe osteoporosis: a clinical challenge.

Abdel-Kader N, Cardiel MH, Navarro Compan V, Piedra Priego J, González A.

Reumatol Clin. 2012 Sep-Oct;8(5):278-9. Epub 2012 Mar 14.

Supplemental Content

Loading ...
Support Center